Availability of data and materials
F. Fitzal had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
F. Fitzal received personal honoraria and educational grants from Pfizer, Novartis, Roche, Astra Zeneca, Springer, Medtronic, and Bondimed. W.P. Weber has received research support from Takeda Pharmaceuticals International via Swiss Group for Clinical Cancer Research (SAKK), honoraria/consultation from Genomic Health, Inc., USA, and support paid to the University Hospital Basel for conferences and meetings from Sandoz, Genomic Health, Medtronic, Novartis Oncology, Pfizer, and Eli Lilly.
No other authors have conflicts of interest disclosures to report.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Fitzal, F., Bolliger, M., Dunkler, D. et al. ASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study. Ann Surg Oncol 29, 1073–1075 (2022). https://doi.org/10.1245/s10434-021-10898-y